LabCorp (LH) Director Kerrii B. Anderson Sells 3,000 Shares

What Happened Kerrii B. Anderson, a director of LabCorp Holdings Inc. (LH), sold 3,000 shares on 2026-08-17 at $318.02 per share, generating proceeds of $954,060. The filing reports the transaction as an open-market/private sale and includes a footnote that the sale was made pursuant to a Rule 10b5-1 trading plan. This is a sale (not a purchase), which is commonly routine when done under a pre-established plan.

Key Details

• Transaction date and price: 2026-08-17 — 3,000 shares at $318.02 each.
• Total value: $954,060.
• Filing date: 2026-08-18 (covers the 2026-08-17 transaction) — appears timely (within the typical two-business-day Form 4 window).
• Shares owned after transaction: not specified in the provided filing.
• Footnote: Sale executed pursuant to a Rule 10b5-1 trading plan (prearranged plan).

Context A 10b5-1 plan indicates the sale was prearranged and executed according to a plan that allows insiders to sell shares at scheduled times, which often reduces the indication of current personal views on the stock. Sales under such plans are common and don’t necessarily signal a change in outlook; purchases are typically more informative about insider sentiment.